Johnson & Johnson have set aside $3.9 billion in litigation expenses in 2020 according to a recent securities filing. According to the drugmaker, the money is primarily associated with talc-related reserves and settlements.
While back in November J&J appealed a $2.12 billion award to women that accused the company's baby powder and talc products of being asbestos laced, which caused their cancers, that verdict was eventually upheld.
The company still faces 25,000 lawsuits by baby powder users. The amount that J&J have now reserved is nearly double the $2.1 billion the company said in November it would set aside for these verdicts.
Read the Reuters report